Vheda Health Closes Record 2025 with Market-Leading Outcomes, New Partnerships, and Workforce Growth

In 2025, Vheda Health achieved its largest growth on record - launching its chronic, behavioral health, and maternity programs across six new markets - driving 2,001% revenue growth and a 4,049% membership increase since 2021 through consistent 80%+ engagement and double-digit medical cost savings, reinforcing its leadership as the premier virtual health engagement solution for Medicaid, Medicare, and SNP health plans.

COLUMBIA, MARYLAND / ACCESS Newswire / January 13, 2026 / Vheda Health, a nationally certified Minority Business and leader in virtual health engagement, concludes 2025 with record gains through new and expanded health plan partnerships, educational leadership, and workforce growth. As a result, the company gained national recognition as the go-to partner for Medicaid, Medicare, and SNP plans seeking to accelerate health equity for everyone by providing simple access to care from anywhere.

"The close of each year brings reflection and 2025 was a defining year for Vheda Health," said Shameet Luhar, CEO and Co-Founder of Vheda Health. "From launching partnerships with new states and health plans, to receiving national recognition for Vheda's workplace culture, 2026 will be the year Vheda becomes the destination health plan partner and employer for members and employees across the country."

Vheda Health's 2025 Accomplishments include:

6 National Program Launches

• New National Partnerships: 40%+ member growth through new and expanded chronic, behavioral, and maternal programs in 6 states, including California, Iowa, Pennsylvania, Louisiana, New Mexico, and Oklahoma.

Actuarially Validated Health Plan Outcomes

• Increased medical cost reduction and utilization impact: $600-$1,150+ PMPM savings, driving 32-34%reduction in inpatient spend.

• Positive maternal health outcomes: 38.6 weeks average gestation at delivery, 83% postpartum care completion.

• Sustained monthly member engagement: 80%+ member engagement and device adherence.

• Higher STAR ratings: Delivered statistically significant HEDIS gains by improving core measures from below the 10th NCQA percentile to above the 50th, 75th, and 95th percentile, for Breast Cancer Screening (BCS-E), Controlling Blood Pressure (CBP), Statin Therapy for Patients with Cardiovascular Disease (SPC), Statin Therapy for Patients with Diabetes (SPD), and Adults' Access to Preventive/Ambulatory Health Services (AAP).